Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

Microneedling mildly regrows hair in androgenetic alopecia but not in other types.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

PRP therapy effectively treats alopecia areata and atrophic acne scars.

Tofacitinib is an effective and safe treatment for alopecia areata.

Disulfide bonds are crucial for hair's strength, especially when wet.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Phosphorus homeopathy treatment led to complete hair regrowth in two Alopecia Areata patients.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

A woman's hair grew back with baricitinib treatment, but she developed a temporary hairy tongue that was treated with regular tongue brushing.

Adding PRP to topical mometasone improves and speeds up alopecia areata treatment.